Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Patient Educ Couns. 2022 Jan 31;105(7):2217–2224. doi: 10.1016/j.pec.2022.01.015

Table 2.

Postoperative Pain and Analgesic Outcomes in the Groups (sample = 399, or those with long-term follow-up data).

Control (n = 173) STOMP (n = 226) OR/MD [95% CI], p value
Worst pain intensity (NRS 0–10)
  Average postoperatively 4.3 ± 2.1 4.3 ± 2.0 MD 0.04 [−0.37, 0.45],.847
  Day 7 7.0 ± 2.3 7.3 ± 2.1
  Day 14 4.2 ± 2.6 4.3 ± 2.6
  Month 1–3 2.9 ± 2.4 2.7 ± 2.5
PROMIS Pain Interference (0–32) 8.1 ± 7.7 6.2 ± 6.9 MD 1.83 [0.38, 3.27],.013
Days non-opioid used M 14 IQR 7–30 M 15 IQR 8–30 p = .366 *
Days opioid used M 4 IQR 3–7 M 4 IQR 2–7 p = .714 *
 No use (vs. any use) 20 (11.6%) 22 (9.8%) 1.21 [0.64, 2.29],.563
  Minimal use (1–4 days) 106 (61.6%) 140 (62.5%)
  Moderate use (5–9 days) 20 (11.6%) 29 (12.9%) 0.97 [0.56, 1.69],.915
  Prolonged use (≥ 10 days, vs less) 26 (15.1%) 33 (14.7%)
Postoperative opioid misuse behavior 12 (7.0%) 18 (8.0%) 1.15 [0.54, 2.47],.712
Postoperative opioid misuse intention 38 (22%) 47 (20.8%) 0.93 [0.58, 1.51],.777

Abbreviations: NRS = Numeric rating scale; PROMIS = Patient-reported outcome measures information system; Data are presented as mean ± standard deviation; n (%); median (M) with interquartile range (IQR); odds ratio (OR) or mean difference (MD) with 95% confidence intervals (CI)

*

compared with Mann-Whitney U test